Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03167970 · ClinicalTrials.gov registry record
Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy
A clinical trial, sponsored by Midwest Biomedical Research Foundation.
- Completed
- Registry status
- 21
- Enrollment target
NCT03167970: Completed study, sponsored by Midwest Biomedical Research Foundation.
NCT03167970 is a clinical trial that has completed, run by Midwest Biomedical Research Foundation. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03167970 has completed, sponsored by Midwest Biomedical Research Foundation.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
This study is to examine the benefits of newly designed capsule with enhanced frame rate and wide angle compared to standard endoscopy, which may help enhance detecting esophageal diseases that otherwise may have been out of vision in the standard endoscopy, ultimately decreasing healthcare costs.
Primary Outcome
The ability to accurately predict the presence of Barrett's esophagus by capsule endoscopy and standard EGD will be measured.
Interventions
- DEVICE Pill cam
- OTHER EGD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-05-03 |
| Est. Completion | 2018-01-14 |
What the finished NCT03167970 record still lists
NCT03167970 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Pill cam is the first listed.
NCT03167970 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03167970 about?
NCT03167970 is a clinical study titled "Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy". This study is to examine the benefits of newly designed capsule with enhanced frame rate and wide angle compared to standard endoscopy, which may help enhance detecting esophageal diseases that otherwise may have been out of vision in the standard endoscopy, ultimately decreasing healthcare costs.
What is the current status of trial NCT03167970?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2017-05-03. Estimated completion is 2018-01-14.
What interventions are being tested in trial NCT03167970?
The interventions under investigation include: Pill cam (DEVICE), EGD (OTHER).
Who is sponsoring clinical trial NCT03167970?
This trial is sponsored by Midwest Biomedical Research Foundation, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI